Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics

被引：0
|
作者：
Gisondi, Paolo [1 ]
Bellinato, Francesco [1 ]
Idolazzi, Luca [2 ]
Zabotti, Alen [3 ,4 ]
McGonagle, Dennis [4 ,5 ]
Girolomoni, Giampiero [1 ]
机构：
[1] Univ Verona, Sect Dermatol, Verona, Italy
[2] Univ Verona, Sect Rheumatol, Verona, Italy
[3] Azienda Sanit Univ Friuli Cent, Udine, Italy
[4] NIHR Leeds Biomed Res Ctr, LTHT, Leeds, England
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
D O I：
10.1093/bjd/ljae360.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FC29
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment persistence of biologics among patients with psoriatic arthritis
    Haddad, Amir
    Gazitt, Tal
    Feldhamer, Ilan
    Feld, Joy
    Cohen, Arnon Dov
    Lavi, Idit
    Tatour, Faten
    Bergman, Irena
    Zisman, Devy
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [22] Psoriatic arthritis risk in psoriasis patients in the Corrona® Psoriasis Registry
    Ogdie, A.
    Harrison, R. W.
    McLean, R. R.
    Lin, T.
    Lebwohl, M.
    Strober, B.
    Zhuo, J.
    Patel, V.
    Mease, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S53 - S53
  • [23] Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis
    Jin, Yinzhu
    Lee, Hemin
    Lee, Moa P.
    Landon, Joan E.
    Merola, Joseph F.
    Desai, Rishi J.
    Kim, Seoyoung C.
    ARTHRITIS CARE & RESEARCH, 2022, 74 (11) : 1792 - 1805
  • [24] Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
    Vegas, Laura Pina
    Le Corvoisier, Philippe
    Penso, Laetitia
    Paul, Muriel
    Sbidian, Emilie
    Claudepierre, Pascal
    RHEUMATOLOGY, 2022, 61 (04) : 1589 - 1599
  • [25] The Epidemiology of Psoriatic Arthritis in The Era of Biologics Given for Psoriasis
    Solmaz, Dilek
    Ehlebracht, Alexa
    Karsh, Jacob
    Bakirci, Sibel
    McGonagle, Dennis
    Aydin, Sibel
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 801 - 801
  • [26] TREATMENT PATTERNS OF BIOLOGICS AND APREMILAST AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS BY PSORIATIC ARTHRITIS STATUS
    Feldman, S. R.
    Zhang, J.
    Martinez, D.
    Lopez-Gonzalez, L.
    Marchlewicz, E.
    Shrady, G.
    Lowry, S.
    Mendelsohn, A. B.
    Zhao, Y.
    VALUE IN HEALTH, 2019, 22 : S55 - S55
  • [27] New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection
    Ceccarelli, Manuela
    Rullo, Emmanuele Venanzi
    Berretta, Massimiliano
    Cacopardo, Bruno
    Pellicano, Giovanni Francesco
    Nunnari, Giuseppe
    Guarneri, Claudio
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [28] Switching biologics in the treatment of psoriatic arthritis
    Merola, Joseph F.
    Lockshin, Benjamin
    Mody, Elinor A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (01) : 29 - 37
  • [29] AN AUDIT OF THE TREATMENT OF PSORIATIC ARTHRITIS WITH BIOLOGICS
    Rawlings, Charlotte
    Negi, Anurag
    Choy, Ernest
    RHEUMATOLOGY, 2015, 54 : 198 - 199
  • [30] METHOD FOR ASSESSING THE PROBABILITY OF DEVELOPING PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS
    Liashko, Y. Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S619 - S619
12345